Related Experiment Videos
[Targeting therapy for renal cancer]
1Dept. of Urology, Akita University School of Medicine.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|May 1, 1994
Abstract:
Renal cancer is a typical tumor most insensitive to standard chemotherapy, but this hypervascular tumor has an anatomical feature by which its main feeding artery is readily accessible to transarterial targeting treatments. Effects of arterial chemoembolization, a prototype targeting chemotherapy, on renal cancer were reviewed.
Insights
Renal cancer is resistant to chemotherapy. Arterial chemoembolization offers a targeted treatment approach by delivering chemotherapy directly to the kidney tumor's blood supply.
Area of Science:
- Oncology
- Interventional Radiology
Context:
- Renal cancer is characterized by resistance to conventional systemic chemotherapy.
- The hypervascular nature of renal tumors presents a unique anatomical target.
- The main artery supplying the renal tumor is accessible for targeted interventions.
Purpose:
- To review the effects of arterial chemoembolization as a targeted chemotherapy approach for renal cancer.
- To evaluate the efficacy and application of transarterial treatments in managing renal tumors.
Summary:
- Renal tumors are typically unresponsive to standard chemotherapy.
- Arterial chemoembolization delivers chemotherapy directly to the tumor via its feeding artery.
- This review examines the outcomes of this targeted treatment modality for renal cancer.
Impact:
- Highlights the potential of transarterial chemoembolization as a treatment for renal cancer.
- Suggests a viable alternative for patients with chemotherapy-resistant renal tumors.
- Emphasizes the importance of anatomical targeting in cancer therapy.